Potential Targeted Therapies in Ovarian Cancer.

Yagmur SismanLau Kræsing VestergaardDouglas Nogueira Perez de OliveiraTim Svenstrup PoulsenTine Henrichsen SchnackClaus HøgdallEstrid V S Høgdall

Published in: Pharmaceuticals (Basel, Switzerland) (2022)

PARP inhibitors are the most frequent potential targeted therapy in HGSC. However, other targeted therapies remain relevant for investigation according to our mutational findings.

Keyphrases

dna damage
human health
dna repair
risk assessment